# KITLG

## Overview
KITLG, or the KIT ligand gene, encodes the KIT ligand protein, also known as stem cell factor (SCF), which is a critical component in cellular signaling. The KIT ligand is a cytokine that functions primarily as a ligand for the c-KIT receptor, a transmembrane receptor tyrosine kinase. This interaction is pivotal for the regulation of various biological processes, including hematopoiesis, melanogenesis, and gametogenesis. The KITLG gene is expressed in multiple isoforms, which can exist in both soluble and membrane-bound forms, each playing distinct roles in cellular communication and development (Childs2009Activin; Lammie1994Expression). Mutations and polymorphisms in KITLG have been associated with several clinical conditions, such as familial progressive hyperpigmentation and hypopigmentation (FPHH) and testicular germ cell tumors (TGCTs), underscoring its significance in both normal physiology and disease states (Kanetsky2009Common; Amyere2011KITLG).

## Structure
The KITLG protein, also known as the stem cell factor (SCF), is a ligand for the KIT receptor tyrosine kinase. It plays a crucial role in various biological processes, including melanocyte development and pigmentation. The primary structure of KITLG consists of a sequence of amino acids, with a highly conserved VTNNV motif (amino acids 33-37) that is critical for its binding functions (Wang2021Identification). This motif is located within the third beta-strand of the protein, which is essential for its interaction with the c-KIT receptor (Picardo2011The).

The secondary structure of KITLG includes beta strands, which contribute to its binding capabilities. The tertiary structure involves the overall 3D folding of the protein, which is crucial for its function. Mutations in the KITLG gene, particularly within the VTNNV motif, can lead to familial progressive hyper- and hypopigmentation (FPHH) by altering the protein's structure and function (Zhang2016Report; Wang2021Identification).

Post-translational modifications such as glycosylation and phosphorylation are common in KITLG, affecting its stability and function. Alternative splicing of the KITLG gene results in different isoforms, which may have distinct roles in cellular signaling and development (Oltova2020Zebrafish).

## Function
The KITLG gene, also known as Kit ligand or stem cell factor (SCF), encodes a protein that plays a crucial role in various cellular processes by binding to the c-KIT receptor, a transmembrane tyrosine kinase. This interaction is essential for the survival, proliferation, and differentiation of several cell types, including hematopoietic stem cells, melanocytes, and germ cells (Galan2006Association; Lammie1994Expression). KITLG exists in two isoforms: a soluble form and a membrane-bound form. The soluble form acts as a paracrine factor, while the membrane-bound form functions in a juxtacrine manner, leading to sustained receptor activation and greater stability (Childs2009Activin; Zhao2020Regulation).

In the context of human fetal ovaries, KITLG is involved in the signaling pathway between somatic and germ cells, playing a critical role in normal female germline development by preventing premature primordial follicle formation (Childs2009Activin). In addition, KITLG is implicated in pigmentation differences among human populations, influencing melanocyte migration, proliferation, and survival, which are crucial for maintaining normal melanocyte numbers in adults (Miller2007cisRegulatory). The gene's expression is developmentally regulated, ensuring proper cellular and organismal outcomes.

## Clinical Significance
Mutations and variations in the KITLG gene are associated with several clinical conditions. KITLG mutations can lead to familial progressive hyperpigmentation and hypopigmentation (FPHH), an autosomal dominant disorder characterized by progressive diffuse hyperpigmented lesions, café-au-lait spots, and hypopigmented maculae. These mutations are located in a conserved sequence of the gene, causing a gain of function that affects melanin synthesis and melanocyte development (Amyere2011KITLG; Picardo2011The). The same mutations have been linked to familial progressive hyperpigmentation (FPH), suggesting environmental factors may influence the phenotype (Picardo2011The).

KITLG is also implicated in testicular germ cell tumors (TGCTs). Certain single nucleotide polymorphisms (SNPs) in KITLG, such as rs3782179 and rs4474514, are associated with a significantly increased risk of TGCT, highlighting the gene's role in tumor susceptibility (Kanetsky2009Common; Nemtsova2016Polymorphisms). Additionally, KITLG variations may contribute to male infertility, particularly in conditions like oligospermia, due to its role in spermatogenesis (Cheng2013SNPs). Despite investigations, no significant mutations in the KITLG gene have been linked to 46,XX spontaneous premature ovarian failure, suggesting its mutations are not a common cause of this condition (Hui2006Investigation).

## Interactions
KITLG, also known as stem cell factor (SCF), is involved in several critical protein interactions that influence various biological processes. One of the primary interactions of KITLG is with the c-KIT receptor, a type of receptor tyrosine kinase. This interaction is essential for the activation of downstream signaling pathways, including the PI3K/AKT pathway, which plays a significant role in cell proliferation, survival, and apoptosis (Mao2024The; Qin2024Exploring).

In the context of ovarian folliculogenesis in buffalo, KITLG interacts with Keratinocyte Growth Factor (KGF), forming a complex that is crucial for follicular development. This interaction was confirmed through co-immunoprecipitation assays and computational modeling, which identified specific amino acid residues involved in the complex formation (Panwar2015Cross).

KITLG also participates in the regulation of gene expression through the STAT3/SMAD2 signaling pathway, particularly in hepatocellular carcinoma with portal vein tumor thrombosis. This interaction enhances the expression of COL4A1, facilitating tumor growth and metastasis (Mao2024The).

These interactions highlight KITLG's role in various physiological and pathological processes, including its potential as a therapeutic target in cancer treatment.


## References


[1. (Nemtsova2016Polymorphisms) M. V. Nemtsova, E. V. Ivkin, O. A. Simonova, V. V. Rudenko, V. B. Chernykh, D. S. Mikhaylenko, and O. B. Loran. Polymorphisms of kitlg, spry4, and bak1 genes in patients with testicular germ cell tumors and individuals with infertility associated with azfc deletion of the y chromosome. Molecular Biology, 50(6):845–851, November 2016. URL: http://dx.doi.org/10.1134/S0026893316050137, doi:10.1134/s0026893316050137. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1134/S0026893316050137)

[2. (Amyere2011KITLG) Mustapha Amyere, Thomas Vogt, Joe Hoo, Flemming Brandrup, Anette Bygum, Laurence Boon, and Miikka Vikkula. Kitlg mutations cause familial progressive hyper- and hypopigmentation. Journal of Investigative Dermatology, 131(6):1234–1239, June 2011. URL: http://dx.doi.org/10.1038/jid.2011.29, doi:10.1038/jid.2011.29. This article has 57 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/jid.2011.29)

3. (Oltova2020Zebrafish) Zebrafish Kit ligands cooperate with erythropoietin to promote erythroid cell expansion. This article has 0 citations.

[4. (Mao2024The) Feifei Mao, Yuqiang Cheng, Kang Wang, Zongtao Chai, Lei Guo, Yanyan Xu, Xue Chen, Jie Shi, Weixing Guo, Junling Liu, and Shuqun Cheng. The kit ligand kitlg promotes portal vein tumor thrombosis by up-regulating col4a1 through stat3-smad2 signaling in hepatocellular carcinoma. Acta Materia Medica, 2024. URL: http://dx.doi.org/10.15212/amm-2023-0049, doi:10.15212/amm-2023-0049. This article has 0 citations.](https://doi.org/10.15212/amm-2023-0049)

[5. (Zhao2020Regulation) Meng Zhao, Yunshin Jung, Zewen Jiang, and Katrin J. Svensson. Regulation of energy metabolism by receptor tyrosine kinase ligands. Frontiers in Physiology, April 2020. URL: http://dx.doi.org/10.3389/fphys.2020.00354, doi:10.3389/fphys.2020.00354. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2020.00354)

[6. (Childs2009Activin) Andrew J. Childs and Richard A. Anderson. Activin a selectively represses expression of the membrane-bound isoform of kit ligand in human fetal ovary. Fertility and Sterility, 92(4):1416–1419, October 2009. URL: http://dx.doi.org/10.1016/j.fertnstert.2009.03.095, doi:10.1016/j.fertnstert.2009.03.095. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.fertnstert.2009.03.095)

[7. (Zhang2016Report) J. Zhang, R. Cheng, J. Liang, C. Ni, M. Li, and Z. Yao. Report of a child with sporadic familial progressive hyper- and hypopigmentation caused by a novelkitlgmutation. British Journal of Dermatology, 175(6):1369–1371, September 2016. URL: http://dx.doi.org/10.1111/bjd.14694, doi:10.1111/bjd.14694. This article has 11 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1111/bjd.14694)

[8. (Galan2006Association) J.J. Galan, M. De Felici, B. Buch, M.C. Rivero, A. Segura, J.L. Royo, N. Cruz, L.M. Real, and A. Ruiz. Association of genetic markers within the kit and kitlg genes with human male infertility. Human Reproduction, 21(12):3185–3192, August 2006. URL: http://dx.doi.org/10.1093/humrep/del313, doi:10.1093/humrep/del313. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/humrep/del313)

[9. (Wang2021Identification) Jianbo Wang, Weisheng Li, Naihui Zhou, Jingliu Liu, Shoumin Zhang, Xueli Li, Zhenlu Li, Ziliang Yang, Miao Sun, and Min Li. Identification of a novel mutation in the kitlg gene in a chinese family with familial progressive hyper- and hypopigmentation. BMC Medical Genomics, January 2021. URL: http://dx.doi.org/10.1186/s12920-020-00851-5, doi:10.1186/s12920-020-00851-5. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12920-020-00851-5)

[10. (Hui2006Investigation) Emily S. Hui, Ekemini A. Udofa, Jackeline Soto, Vien H. Vanderhoof, Keith Zachman, Zhi-Bin Tong, and Lawrence M. Nelson. Investigation of the human stem cell factor kit ligand gene, kitlg, in women with 46,xx spontaneous premature ovarian failure. Fertility and Sterility, 85(5):1502–1507, May 2006. URL: http://dx.doi.org/10.1016/j.fertnstert.2005.10.071, doi:10.1016/j.fertnstert.2005.10.071. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.fertnstert.2005.10.071)

[11. (Qin2024Exploring) Liuqing Qin, Yuchao Li, Yifei Huang, Chaoyi Tang, Wenkang Yang, Yujun Tang, Caixin Qiu, Min Mao, and Jiehua Li. Exploring the biological behavior and underlying mechanism of kitlg in triple-negative breast cancer. Journal of Cancer, 15(3):764–775, 2024. URL: http://dx.doi.org/10.7150/jca.90051, doi:10.7150/jca.90051. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.90051)

[12. (Panwar2015Cross) Deepak Panwar, Leena Rawal, Neeta Sehgal, and Sher Ali. Cross talk between kgf and kitlg proteins implicated with ovarian folliculogenesis in buffalo bubalus bubalis. PLOS ONE, 10(6):e0127993, June 2015. URL: http://dx.doi.org/10.1371/journal.pone.0127993, doi:10.1371/journal.pone.0127993. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0127993)

[13. (Miller2007cisRegulatory) Craig T. Miller, Sandra Beleza, Alex A. Pollen, Dolph Schluter, Rick A. Kittles, Mark D. Shriver, and David M. Kingsley. Cis-regulatory changes in kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans. Cell, 131(6):1179–1189, December 2007. URL: http://dx.doi.org/10.1016/j.cell.2007.10.055, doi:10.1016/j.cell.2007.10.055. This article has 303 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2007.10.055)

[14. (Cheng2013SNPs) Pan Cheng, Hui Chen, Shuo-Ran Liu, Xiao-Ying Pu, and Zhou-Cun A. Snps inkitandkitlggenes may be associated with oligospermia in chinese population. Biomarkers, 18(8):650–654, October 2013. URL: http://dx.doi.org/10.3109/1354750X.2013.838307, doi:10.3109/1354750x.2013.838307. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/1354750X.2013.838307)

[15. (Kanetsky2009Common) Peter A Kanetsky, Nandita Mitra, Saran Vardhanabhuti, Mingyao Li, David J Vaughn, Richard Letrero, Stephanie L Ciosek, David R Doody, Lauren M Smith, JoEllen Weaver, Anthony Albano, Chu Chen, Jacqueline R Starr, Daniel J Rader, Andrew K Godwin, Muredach P Reilly, Hakon Hakonarson, Stephen M Schwartz, and Katherine L Nathanson. Common variation in kitlg and at 5q31.3 predisposes to testicular germ cell cancer. Nature Genetics, 41(7):811–815, May 2009. URL: http://dx.doi.org/10.1038/ng.393, doi:10.1038/ng.393. This article has 261 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.393)

[16. (Lammie1994Expression) A Lammie, M Drobnjak, W Gerald, A Saad, R Cote, and C Cordon-Cardo. Expression of c-kit and kit ligand proteins in normal human tissues. Journal of Histochemistry &amp; Cytochemistry, 42(11):1417–1425, November 1994. URL: http://dx.doi.org/10.1177/42.11.7523489, doi:10.1177/42.11.7523489. This article has 197 citations.](https://doi.org/10.1177/42.11.7523489)

[17. (Picardo2011The) Mauro Picardo and Giorgia Cardinali. The genetic determination of skin pigmentation: kitlg and the kitlg/c-kit pathway as key players in the onset of human familial pigmentary diseases. Journal of Investigative Dermatology, 131(6):1182–1185, June 2011. URL: http://dx.doi.org/10.1038/jid.2011.67, doi:10.1038/jid.2011.67. This article has 44 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/jid.2011.67)